600594 益佰製藥
按盤價 
3.040 +0.040 (+1.333%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.402 | 3.599 | -14.140 | 7.472 | 6.632 |
| 總資產報酬率 ROA (%) | -1.501 | 2.227 | -9.137 | 4.899 | 4.184 |
| 投入資產回報率 ROIC (%) | -1.716 | 2.563 | -10.474 | 5.532 | 4.714 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.575 | 69.471 | 70.963 | 78.754 | 78.995 |
| 營業利潤率 (%) | -11.828 | 4.870 | -13.745 | 9.424 | 9.256 |
| 息稅前利潤/營業總收入 (%) | -10.774 | 5.245 | -13.116 | 10.182 | 9.717 |
| 淨利潤/營業總收入 (%) | -12.470 | 3.239 | -16.442 | 6.896 | 5.932 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.668 | 150.494 | -53.505 | 144.023 | 145.373 |
| 價值變動淨收益/利潤總額(%) | -0.084 | 0.022 | 0.042 | 11.161 | -1.423 |
| 營業外收支淨額/利潤總額(%) | 2.916 | -3.807 | 4.107 | -1.624 | -6.208 | 償債能力分析 |
| 流動比率 (X) | 1.897 | 2.226 | 1.740 | 1.593 | 1.487 |
| 速動比率 (X) | 1.325 | 1.595 | 1.207 | 1.080 | 1.163 |
| 資產負債率 (%) | 34.842 | 34.347 | 35.839 | 30.754 | 34.883 |
| 帶息債務/全部投入資本 (%) | 22.305 | 21.841 | 25.137 | 20.305 | 25.965 |
| 股東權益/帶息債務 (%) | 319.477 | 328.028 | 281.679 | 379.863 | 273.746 |
| 股東權益/負債合計 (%) | 178.703 | 182.676 | 170.342 | 221.220 | 181.115 |
| 利息保障倍數 (X) | -7.646 | 9.479 | -10.769 | 11.209 | 9.700 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.688 | 33.286 | 41.814 | 35.376 | 32.212 |
| 存貨周轉天數 (天) | 239.370 | 253.296 | 267.364 | 266.560 | 228.196 |
| 備註： | 即時報價更新時間為 01/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
